SANA
Sana Biotechnology Inc

4,026
Mkt Cap
$1.07B
Volume
3.92M
52W High
$7.30
52W Low
$1.26
PE Ratio
-4.14
SANA Fundamentals
Price
$4.30
Prev Close
$4.02
Open
$4.06
50D MA
$4.23
Beta
2.02
Avg. Volume
6.35M
EPS (Annual)
-$1.16
P/B
5.40
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Sana Biotechnology (NASDAQ:SANA) Trading 12.8% Higher - Still a Buy?
Sana Biotechnology (NASDAQ:SANA) Shares Up 12.8% - Still a Buy...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Stock Rating Lowered by Wall Street Zen
Wall Street Zen lowered shares of Sana Biotechnology from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·6d ago
News Placeholder
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of "Moderate Buy" by Brokerages
Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) has been given an average rating of "Moderate Buy" by the nine brokerages that are covering the company, Marketbeat Ratings reports. One...
MarketBeat·10d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Shares Down 7.1% - Time to Sell?
Sana Biotechnology (NASDAQ:SANA) Trading Down 7.1% - Here's What Happened...
MarketBeat·10d ago
News Placeholder
Top 3 Genomics Stocks to Consider for Your Portfolio
Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequencing and gene editing.
Zacks·10d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Trading Up 9.2% - Should You Buy?
Sana Biotechnology (NASDAQ:SANA) Stock Price Up 9.2% - What's Next...
MarketBeat·12d ago
News Placeholder
All You Need to Know About Sana (SANA) Rating Upgrade to Buy
Sana (SANA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·16d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Sana Biotechnology from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·19d ago
News Placeholder
Wedbush Forecasts Strong Price Appreciation for Sana Biotechnology (NASDAQ:SANA) Stock
Wedbush upped their price target on shares of Sana Biotechnology from $5.00 to $6.00 and gave the company an "outperform" rating in a report on Friday...
MarketBeat·20d ago
News Placeholder
Sana Biotechnology (NASDAQ:SANA) Given New $9.00 Price Target at HC Wainwright
HC Wainwright lowered their price target on Sana Biotechnology from $11.00 to $9.00 and set a "buy" rating on the stock in a research note on Friday...
MarketBeat·20d ago

Latest SANA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.